• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-肌动蛋白是骨髓瘤细胞中 PI3K/AKT 信号通路的下游效应因子。

β-Actin is a downstream effector of the PI3K/AKT signaling pathway in myeloma cells.

机构信息

Department of Chemistry and Institute of Chemistry, National Dong Hwa University, Hualien, Taiwan.

出版信息

Mol Cell Biochem. 2011 Feb;348(1-2):129-39. doi: 10.1007/s11010-010-0647-7. Epub 2010 Nov 11.

DOI:10.1007/s11010-010-0647-7
PMID:21069433
Abstract

Interleukin 6 is the in vivo growth factor of myeloma cells. In response to IL-6 stimulation, the PI3K/AKT signaling pathway is activated in these cells. With comparative proteomic approaches, this study reveals many putative downstream effectors of the PI3K/AKT pathway. Mass spectrometry analysis of excised protein spots from 2-dimensional gel allowed the identification of proteins such as β-Actin, cyclophilin A, E3 SUMO-protein ligase PIAS-NY protein, HSP 27, PML, and transforming growth factor β-2. Among these putative effectors, β-Actin was chosen for further characterization. Phosphorylation of β-Actin by AKT upon IL-6 stimulation was confirmed by western blotting using a phospho-AKT substrate antibody. Interestingly, IL-6 significantly increased cell migration (P < 0.05) and the content of filamentous actin (P < 0.05). Therefore, IL-6 stimulation could have effects on the migration of myeloma cells, and the phosphorylation of β-Actin is probably involved in the process.

摘要

白细胞介素 6 是骨髓瘤细胞的体内生长因子。在受到白细胞介素 6 的刺激后,这些细胞中的 PI3K/AKT 信号通路被激活。通过比较蛋白质组学方法,本研究揭示了 PI3K/AKT 通路的许多潜在下游效应物。从 2 维凝胶中切下的蛋白斑点的质谱分析允许鉴定出诸如β-肌动蛋白、亲环蛋白 A、E3 SUMO-蛋白连接酶 PIAS-NY 蛋白、HSP27、PML 和转化生长因子β-2 等蛋白。在这些潜在的效应物中,β-肌动蛋白被选择用于进一步表征。通过使用磷酸化 AKT 底物抗体进行 Western blot 验证了 AKT 在白细胞介素 6 刺激下对 β-肌动蛋白的磷酸化。有趣的是,白细胞介素 6 显著增加了细胞迁移(P < 0.05)和丝状肌动蛋白的含量(P < 0.05)。因此,白细胞介素 6 的刺激可能对骨髓瘤细胞的迁移有影响,而β-肌动蛋白的磷酸化可能参与了这一过程。

相似文献

1
β-Actin is a downstream effector of the PI3K/AKT signaling pathway in myeloma cells.β-肌动蛋白是骨髓瘤细胞中 PI3K/AKT 信号通路的下游效应因子。
Mol Cell Biochem. 2011 Feb;348(1-2):129-39. doi: 10.1007/s11010-010-0647-7. Epub 2010 Nov 11.
2
Proteomics exploration reveals that actin is a signaling target of the kinase Akt.蛋白质组学研究表明,肌动蛋白是激酶Akt的信号转导靶点。
Mol Cell Proteomics. 2007 Jan;6(1):114-24. doi: 10.1074/mcp.M600335-MCP200. Epub 2006 Nov 4.
3
Cyclophilin A as a downstream effector of PI3K/Akt signalling pathway in multiple myeloma cells.亲环素A作为多发性骨髓瘤细胞中PI3K/Akt信号通路的下游效应分子。
Cell Biochem Funct. 2015 Dec;33(8):566-74. doi: 10.1002/cbf.3156.
4
A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells.一种与 Lyn、PI 3-kinase 和 Akt 相关的新型信号通路支持骨髓瘤细胞的增殖。
Biochem Biophys Res Commun. 2010 Feb 12;392(3):415-20. doi: 10.1016/j.bbrc.2010.01.038. Epub 2010 Jan 15.
5
Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.蛋白质组学鉴定14-3-3ζ作为胰岛素样生长因子-1(IGF-1)与Akt/糖原合成酶激酶-3β(GSK-3β)信号传导的衔接蛋白以及肾系膜细胞存活的相关蛋白
Int J Biol Sci. 2006 Oct 27;3(1):27-39. doi: 10.7150/ijbs.3.27.
6
[Transforming growth factor beta regulates hepatic progenitor cells migration via PI3K/AKT/mTOR/p70S6K pathway].[转化生长因子β通过PI3K/AKT/mTOR/p70S6K信号通路调控肝祖细胞迁移]
Zhonghua Gan Zang Bing Za Zhi. 2018 Sep 20;26(9):680-685. doi: 10.3760/cma.j.issn.1007-3418.2018.09.009.
7
Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.多发性骨髓瘤肿瘤细胞暴露于白细胞介素-6后,参与p70S6K激活和4E-BP1磷酸化的信号通路。
J Biol Chem. 2002 May 3;277(18):15712-20. doi: 10.1074/jbc.M200043200. Epub 2002 Feb 28.
8
CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling.CD40通过磷脂酰肌醇3激酶/AKT/核因子κB信号传导诱导人多发性骨髓瘤细胞迁移。
Blood. 2003 Apr 1;101(7):2762-9. doi: 10.1182/blood-2002-09-2813. Epub 2002 Nov 14.
9
Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.表皮生长因子通过 PI3K/Akt/mTOR 信号通路诱导 PANC-1 胰腺癌细胞中 HCCR 的表达。
BMC Cancer. 2010 Apr 27;10:161. doi: 10.1186/1471-2407-10-161.
10
Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.通过 Runx2 siRNA 诱导抑制 PI3K/AKT 信号通路治疗瘢痕疙瘩。
Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11693. Epub 2020 Nov 17.

引用本文的文献

1
Role of Akt/Protein Kinase B in Cancer Metastasis.Akt/蛋白激酶B在癌症转移中的作用。
Biomedicines. 2023 Nov 8;11(11):3001. doi: 10.3390/biomedicines11113001.
2
Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling.靶向酸性鞘磷脂酶抑制通过降低 AKT 信号通路抑制神经胶质瘤细胞迁移。
Cells. 2022 Jun 9;11(12):1873. doi: 10.3390/cells11121873.
3
Defining the Akt1 interactome and its role in regulating the cell cycle.定义 Akt1 相互作用组及其在调节细胞周期中的作用。

本文引用的文献

1
Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.亲环蛋白有助于信号转导及转录激活因子3信号传导和多发性骨髓瘤细胞的存活。
Oncogene. 2009 Aug 6;28(31):2784-95. doi: 10.1038/onc.2009.142. Epub 2009 Jun 8.
2
Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.小泛素样修饰蛋白(SUMO)在RNF4介导的早幼粒细胞白血病蛋白(PML)降解中的作用:PML的SUMO化及其SUMO结合结构域的磷酸化开关调控在活细胞中的解析
J Biol Chem. 2009 Jun 12;284(24):16595-16608. doi: 10.1074/jbc.M109.006387. Epub 2009 Apr 20.
3
Sci Rep. 2018 Jan 22;8(1):1303. doi: 10.1038/s41598-018-19689-0.
4
AGC family kinase 1 participates in trogocytosis but not in phagocytosis in Entamoeba histolytica.AGC家族激酶1参与溶组织内阿米巴的 trogocytosis 过程,但不参与吞噬作用。
Nat Commun. 2017 Jul 17;8(1):101. doi: 10.1038/s41467-017-00199-y.
5
Jujuboside A Protects H9C2 Cells from Isoproterenol-Induced Injury via Activating PI3K/Akt/mTOR Signaling Pathway.酸枣仁皂苷A通过激活PI3K/Akt/mTOR信号通路保护H9C2细胞免受异丙肾上腺素诱导的损伤。
Evid Based Complement Alternat Med. 2016;2016:9593716. doi: 10.1155/2016/9593716. Epub 2016 May 16.
6
Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle.Akt2 激酶的氧化促进细胞迁移,并调节细胞周期中的 G1-S 转换。
Cell Cycle. 2011 Oct 1;10(19):3263-8. doi: 10.4161/cc.10.19.17738.
c-Met signaling promotes IL-6-induced myeloma cell proliferation.
c-Met信号传导促进白细胞介素-6诱导的骨髓瘤细胞增殖。
Eur J Haematol. 2009 Apr;82(4):277-87. doi: 10.1111/j.1600-0609.2009.01212.x. Epub 2009 Jan 6.
4
Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.脯氨酰异构酶亲环素A对Janus激活激酶2的调控与人乳腺癌的进展
Cancer Res. 2008 Oct 1;68(19):7769-78. doi: 10.1158/0008-5472.CAN-08-0639.
5
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3.硝呋齐特通过直接抑制信号转导和转录激活因子3(STAT3)来抑制多发性骨髓瘤细胞的存活。
Blood. 2008 Dec 15;112(13):5095-102. doi: 10.1182/blood-2007-12-129718. Epub 2008 Sep 29.
6
The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells.小GTP酶Ral介导基质细胞衍生因子-1诱导的B细胞和多发性骨髓瘤细胞迁移。
Blood. 2008 Apr 1;111(7):3364-72. doi: 10.1182/blood-2007-08-106583. Epub 2008 Jan 28.
7
Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell derived factor-1 induced migration of CD34+ cells from patients with myelodysplasia.蛋白激酶B、Rac的激活降低以及F-肌动蛋白聚合作用减弱,导致骨髓增生异常综合征患者的基质细胞衍生因子-1诱导的CD34+细胞迁移受损。
Blood. 2008 Jan 1;111(1):359-68. doi: 10.1182/blood-2006-11-060632. Epub 2007 Sep 26.
8
New drugs for myeloma.用于治疗骨髓瘤的新药。
Oncologist. 2007 Jun;12(6):664-89. doi: 10.1634/theoncologist.12-6-664.
9
Proteomics exploration reveals that actin is a signaling target of the kinase Akt.蛋白质组学研究表明,肌动蛋白是激酶Akt的信号转导靶点。
Mol Cell Proteomics. 2007 Jan;6(1):114-24. doi: 10.1074/mcp.M600335-MCP200. Epub 2006 Nov 4.
10
The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival.含缬酪肽蛋白(VCP)是细胞存活所需的Akt信号传导的靶点。
J Biol Chem. 2006 May 19;281(20):14307-13. doi: 10.1074/jbc.M510003200. Epub 2006 Mar 21.